Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases

Details for Australian Patent Application No. 2005201724 (hide)

International Classifications

Event Publications

12 May 2005 Complete Application Filed

19 May 2005 Application Open to Public Inspection

Published as AU-B-2005201724

11 August 2005 Assignment before Grant

SLIL Biomedical Corporation The application has been assigned to CellGate, Inc.

9 October 2008 Alteration of Name

The name of the applicant has been altered to Progen Pharmaceuticals, Inc

16 October 2008 Application Accepted

Published as AU-B-2005201724

12 February 2009 Standard Patent Sealed

25 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.